Skip to main content

Closed

ATOS: Atossa Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

2thpctl

Volume

0.50×avg

Market Cap

20.65MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Atossa Therapeutics, Inc.

ATOSNASDAQ Capital Market·USD·Closed

Atossa Therapeutics, Inc.

ATOSNASDAQ·USD·Closed

$2.07

−5.48%

$2.07

−$0.12 (5.48%)

52W Range

2thpctl

Volume

0.50×avg

Mkt Cap

20.65MUSD

P/E

-0.5TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings